Companies · Other Health Care

Qt Ultrasound Llc

NOVATO · Other Health Care

Diligence memoA one-page analyst read on Qt Ultrasound Llc — recommendation, valuation, rhythm, risks.
$60.3M
Total raised · real
5
Rounds
2.7×
Latest step-up
Top 8%
Sector rank · raised
Series B
Latest stage · inferred · Fri May 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Qt Ultrasound Llc looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.28× the median modeled value of Series B Other Health Care companies in 2016–2018 (74 peers) — value vs value, same stage and era.
  • Within the normal band (128% of peer median) for its niche.
Dormant
  • Last raise 8.1 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Qt Ultrasound Llc behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
13.0 yr record
Peak capital year was 2018 with $95.8M across 2 filings.
Market position
ahead of 93% of Other Health Care peers
Capital scale is ahead of 93% of Other Health Care peers; modeled value is above 94% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2018: $95.8M across 2 filings.
  • Largest single filing was $70.0M on 2018-07-01.
  • Filing rows sum to $130.3M, while canonical raised total is $60.3M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Qt Ultrasound Llc is one of 5377 Other Health Care companies tracked from NOVATO. By capital raised it ranks among the largest (ahead of 93% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
No revenue
Issuer revenue
Rule 506(b)
Reg D exemption
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$500M$1.0B$1.5B$2.0BSeries A · 2013-07-01 Raised $9.0M (real) Modeled valuation $182M (est)$9.0M$182MSeries A2013Series A · 2014-07-01 Raised $7.5M (real) Modeled valuation $151M (est)$7.5M$151MSeries A2014Series A · 2015-07-01 Raised $15M (real) Modeled valuation $303M (est)$15M$303MSeries A2015Series A · 2016-10-01 Raised $3.0M (real) Modeled valuation $60M (est)$3.0M$60MSeries A2016Series B · 2018-05-25 Raised $26M (real) Modeled valuation $572M (est)$26M$572MSeries B2018Series C · 2018-07-01 Raised $70M (real) Modeled valuation $1.6B (est)$70M$1.6BSeries C2018+$7.5M+$15M+$3.0M+$26M+$70MCumulative $130M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$9.0M · 2013
Series A extension$7.5M · 2014
Series A extension$15.0M · 2015
Series A extension$3.0M · 2016
Series B$25.8M · 2018
Series C$70.0M · 2018

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 60%.

Modeled valuation trajectory
$572.1M
Base estimate est.
$60.7M
Conservative case
$2.2B
Upside case
$143.5M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series A · modeled $181.6M · 2013-07-012013Series A · modeled $151.3M · 2014-07-01Series A · modeled $302.7M · 2015-07-01Series A · modeled $60.1M · 2016-10-01Series B · modeled $572.1M · 2018-05-25Series C · modeled $1.6B · 2018-07-012018
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.36×/yr
Annual markup
1.64×/yr upside case
6.0 yr
Elapsed time used
8.1 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
12 mo
Avg between rounds
$12.1M/yr
Capital velocity
13.0 yr
On record since
2013
First round
6
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 25× above median
This company$60.3M
Sector median$2.4M
Latest round — vs other Series B rounds in sector (real $, this stage) 3.9× above median
This company$70.0M
Sector median$17.8M
Modeled value — vs sector median (estimate, all stages) 26× above median
This company$572.1M
Sector median$22.1M

Raised more than 93% of sector peers (real $). Modeled value above 94% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #25 of 74.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0M$1.0BCapital raised (log)Podicare Services, Inc. · Series B Raised $40.0M · modeled $886.2M (est)COTA, Inc. · Series B Raised $43.8M · modeled $886.2M (est)Fresenius Medical Care - Meridian Health System, LLC · Series B Raised $39.0M · modeled $863.9M (est)Headspace, Inc. · Series B Raised $115.9M · modeled $860.6M (est)Spine Holdings LLC · Series B Raised $38.4M · modeled $851.6M (est)Chrono Therapeutics Inc. · Series B Raised $51.4M · modeled $833.2M (est)MedCPU, Inc. · Series B Raised $36.6M · modeled $776.2M (est)Capital Funding Bancorp, Inc. · Series B Raised $35.0M · modeled $775.4M (est)Phreesia, Inc. · Series B Raised $83.8M · modeled $753.2M (est)Labconnect Holdings, Inc. · Series B Raised $33.4M · modeled $739.0M (est)Zoonie, LLC · Series B Raised $52.0M · modeled $708.1M (est)Sotera Wireless, Inc. · Series B Raised $98.5M · modeled $705.3M (est)Qt Ultrasound Llc (this company) Raised $60.3M · modeled $572.1M (est)Qt Ultrasound Llc
CompanyStageRaised · realValue · estvs peer med.
Podicare Services, Inc.Series B$40.0M$886.2M1.98×
COTA, Inc.Series B$43.8M$886.2M1.98×
Fresenius Medical Care - Meridian Health System, LLCSeries B$39.0M$863.9M1.93×
Headspace, Inc.Series B$115.9M$860.6M1.92×
Spine Holdings LLCSeries B$38.4M$851.6M1.90×
Chrono Therapeutics Inc.Series B$51.4M$833.2M1.86×
MedCPU, Inc.Series B$36.6M$776.2M1.73×
Capital Funding Bancorp, Inc.Series B$35.0M$775.4M1.73×
Phreesia, Inc.Series B$83.8M$753.2M1.68×
Labconnect Holdings, Inc.Series B$33.4M$739.0M1.65×
Zoonie, LLCSeries B$52.0M$708.1M1.58×
Sotera Wireless, Inc.Series B$98.5M$705.3M1.58×
Qt Ultrasound Llc this companySeries B$60.3M$572.1M1.28×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$9.0M2013-07-01$40.9M$181.6M85%
Series A$7.5M2014-07-01$34.1M$151.3M85%
Series A$15.0M2015-07-01$68.2M$302.7M85%
Series A$3.0M2016-10-01$13.5M$60.1M90%
Series B$25.8M2018-05-25$143.5M$572.1M90%
Series C$70.0M2018-07-01$466.7M$1.6B90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$9.0M2013-07-01
    • First recorded raise — entered as Series A.
  2. Series A$7.5M2014-07-01
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • Switched to Rule 506(b) (was Rule 06).
  3. Series A$15.0M2015-07-01
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 2.0× larger than the prior — scaling up.
  4. Series A$3.0M2016-10-01
    • Raised 15 mo later, in step with the ~14 mo sector norm.
    • Round 5.0× smaller than the prior — bridge or down round.
    • 5 investors on this round.
  5. Series B$25.8M2018-05-25
    • Raised 20 mo later, in step with the ~14 mo sector norm.
    • Round 8.7× larger than the prior — scaling up.
    • Revenue band moved No revenue → $0–$1M.
    • 251 investors on this round.
  6. Series C$70.0M2018-07-01
    • Came back fast: 1 mo vs the ~14 mo sector norm.
    • Round 2.7× larger than the prior — scaling up.
    • Revenue band moved $0–$1M → No revenue.
Intelligence
2019 ~Q3
Modeled next raise · ~12mo cadence
$189.7M
Modeled next size est.range $123.3M$303.6M
2.7×
Last step-up
$12.1M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Carl C. Jandernoa2014-07
Carl C. Jandersoa2013-07
Carl G. Jandernoa2018-07
Carl M. Jandernoa2018-05
David C. Gentile2013-07
John C. Klock2013-07
John J. Meilner2018-05
Kenneth C. Hungerford2014-07
Kenneth G. Hungerford2013-07
Robert C. Kessler2014-07
Robert Y. Kessler2013-07
Thomas E. Vredevelt, Jr.2018-07
Registry & provenance

Qt Ultrasound Llc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1538864
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Cryolife IncOther Health CareSeries B$60.2M$420.5Msame sector · same stage
HealthTell Inc.Other Health CareSeries B$60.5M$578.2Msame sector · same stage
SlipChip CorpOther Health CareSeries B$59.5M$641.2Msame sector · same stage
Arterys IncOther Health CareSeries B$61.6M$540.3Msame sector · same stage
Neuwave Medical, Inc.Other Health CareSeries B$58.8M$560.7Msame sector · same stage
Teckro, Inc.Other Health CareSeries B$62.3M$366.4Msame sector · same stage
Seno Medical Instruments, IncOther Health CareSeries B$63.2M$673.8Msame sector · same stage
Orthopediatrics CorpOther Health CareSeries B$57.5M$864.0Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Q-Core Powered Imaging, LLCOther Health CarePre-Seed$3.1M86%
Best Imaging, LLCOther Health CarePre-Seed$1.2M83%
Research Imaging Company, LLCOther Health CareSeries C$679.4M83%
Array Radiology, LLCOther Health CarePre-Seed$534K83%
Formal Imaging Experts, LLCOther Health CarePre-Seed$423K82%
Dot Imaging, LLCOther Health CarePre-Seed$381K82%
Total Quality Imaging, LLCOther Health CarePre-Seed$273K82%
Imaging Clarity, LLCOther Health CarePre-Seed$230K82%
Frequently asked
How much funding has Qt Ultrasound Llc raised?
Qt Ultrasound Llc has raised approximately $60.3M in disclosed capital across 5 recorded financing rounds, aggregated from public filings.
What is Qt Ultrasound Llc's estimated valuation?
Provath's modeled valuation for Qt Ultrasound Llc is approximately $572.1M (modeled range $60.7M–$2.2B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Qt Ultrasound Llc at?
Qt Ultrasound Llc's latest modeled financing stage is Series B. Its most recent recorded round closed around Fri May 25.
What does Qt Ultrasound Llc do and where is it based?
Qt Ultrasound Llc operates in the Other Health Care sector, based in NOVATO.
Explore related

See where Qt Ultrasound Llc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Qt Ultrasound Llc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.